Three patients with severe progressive interstitial lung disease refractory to steroid therapy were treated with immunosuppressive drugs. Biopsy material of one showed mainly fibrosis, while that of the second showed interstitial pneumonitis as well; both patients received azathioprine. Cyclophosphamide was employed in the third patient with systemic vasculitis and massive hemoptysis. AU patients had reduced lung volumes and abnormal gas exchange, which continued to worsen on high doses of steroids. In patients 1 and 2, there was long-term stab%-he classification, interstitial lung disease, includes Ta heterogeneous group of disorders resulting from injury to one or more components of the alveolar-capillary membrane from the alveolar epithelium to the capillary endothelium. More than 150 causes have been defined, though in most cases the disorder is idiopathic. With or without a specific etiology, the clinician often empirically treats with steroids with a variable response. Usually, the course remains progressive.
In some instances of interstitial lung disease, nonspecific tissue antibodies and immunologic disorders have been demonstrated and suggest an immunologic basis for this group of diseases. Recently, we encountered three patients with interstitial lung disease who deteriorated despite intensive steroid therapy. On the possibility of an underlying immunologic defect, immunosuppressive drugs were initiated. Our experience with azathioprine and cyclophosphamide in these patients and the rationale for their use follows. zation of lung function, while pulmonary physiologic abnormalities in the patient with vasculitis reverted to normal on five months of cyclophosphamide. Although the etiology of most forms of interstitial lung disease is unknown, several reports suggest at least a partial immunologic basis. Abatement in progression of disease in this small series would suggest that a trial of immunosuppressive drugs be considered in interstitial lung disease when steroid therapy fails.
least one of us. Lung fr~nction tests \\.ere performed at i n t e n d s in the course of their illness.
L'ital capacity and the first-second forced cxpiratory volume (FEV, ) were detennined in a %liter Collins spirometer.
Peak expiratory flo\\r rate ( P F H ) \\.as me;~ssr~retl \vith a peak flo~v meter.' Total l~m g capacity and its s11l)divisions wcLre measured I)y the two-step helil~rn dilution nirthod. M'hile the patient \vas in the recl~m\)ent position under 2 percent procaine local anesthesia, a Riley needle was inserted in a brachial artery. The sr~t)ject I~reathed in a closed systcrn through a Hans-Rudolf valve. .4lveolar air \vas siunpled j~~s t distal to the expiratory valve during a brief voluntary forced expiration given at the end of nomlal expiration. Arterial blood \\.a5 obtained in heparinized syringes. .4lveolar Po2 and Pco2 and arterial pH, Po2 and Pco2 were determined in duplicate at 37% \vith appropriat~ e1ectrodes.t Aleas~~re-rnents were made while the s~~l~j e c t breathed room air and after seven m i n~~t e s of breathing 100 percent oxygen. Carl)on monoxide diffusing capacity ( D L c o ) \vas detennined by the steady state method.' Physiologic dead space was calcrrlatetl from the modified Bohr equation.These techniq~~es as performed in this la1)oratory have been presented previously.:',4
A 62-year-old industrial engineer had reported slo\r'ly progressive dyspnea over several years such that, I)y 1971, he had to rest after climl>ing one flight of stairs. In Jl~ly 1952, hc* reported shortness of breath at rest and a cough prodr~ctive of scant, \r,hitish spntum. Empiric treahnent for "pnerunonia" did not improve symptoms, and he \\,as referred to the !vfassachr~setts General Hospital in Ar~gust 1972. Past medical history was unremarkable except for a hiatal hernia managed symptomatically and essential hypertension treated internlittently with chlortlliazide. He had smoked 1% packages of cigarettes daily for 20 years and had stopped smoking in 'Air-hled Specialties, Ltd., Harlow, Essex, En land. thlodels 123 and 125.4, Instrumentation ~a f o r a t o r y , Cambridge, \lass. 'Azathioprine was hegun after the tests of Xlarrh, 1973 Xlarrh, . 1946 . No occupational exposure to lung toxins could be elicited.
Admission physical examination revealed a tachypneic robust man without cyanosis, clubbing, or signs of congestive heart failure ( C H F ) . Fine crackling rales were audible bilaterally two-thirds the way up each hemithorax. Rheumatoid factor was negative. Chest x-ray film demonstrated loss of lung volume and diffuse infiltrates, more prominent in the lower lung fields. Hallmarks of interstitial lung disease were documented on physiologic studies (Table 1 ) . Open lung biopsy revealed mainly interstitial fibrosis with minimal cellular reaction. Cultures of the biopsy specimen and of multiple sputum samples were negative for fungi and acid-fast bacilli.
In view of progressive respiratory symptoms and reduction in total lung capacity, prednisone 40 mg daily was instih~ted. Physiologic parameters, however, continued to deteriorate (Table 1 ) and a second admission was necessitated in March 1973 for worsening dyspnea and a proximal myopathy, probably related to steroids. Again, there was no evidence of clubbing or CHF. Prednisone was slowly tapered, and azathioprine 200 mg daily was begun. Over the subsequent 12 months, symptoms and lung function stabilized ( Table 1 ) . Roentgenographic appearance of the chest did not change.
CASE 2
A 45-year-old plant superintendent first presented to the hlassachusetts General Hospital in September 1968, with a six-month history of progressive exercise intolerance and eventually dyspnea on climbing one flight of stairs. A smoker of hvo packages of cigarettes daily for 20 years, he discontinued tobacco in 1966. He had recently developed a nonproductive cough, but denied respiratory tract infections, rashes, or joint symptoms. No hazardous occupational exposures could be elicited.
Physical examination revealed an obese man with respiratory rate of 22 and early clubbing. Crackling, "close to the ear," dry rales were audible bilaterally; they increased slightly after coughing. On climbing three flights of stairs, the patient developed dyspnea, cyanosis, and a dry cough.
Hemogram was normal. Rheumatoid factor, antinuclear antibody, and LE preparations were negative. Contracted lung volume and diffusely increased pulmonary markings were apparent on chest x-ray examination. Physiologic tests were consistent with interstitial lung disease ( Table 2 ). Open lung biopsy showed interstitial inflammation and fibrosis, with marked desquarnation of granular pnerlmocytes and increased intirnal thickening. Culture of the biopsy specimen was negative for fungi and acid-fast bacilli.
High dose steroids were begun and gradually tapered to 8 mg of triamcinolone daily. Physiologic parameters, howe\rer, worsened (Table 2 ) , and low flow oxygen was required at home. He was readmitted in December 1971 for left lower lobe pnerunonia and severe dyspnea at rest. While pnerlmonia responded to antibiotics, dyspnea and hypoxemia did not improve; and therefore, azathioprine 200 mg daily was begun in January 1972 and has been continued to the present. During the next 27 months, respiratory symptoms did not change, except during one documented episode of bronchitis which responded to ampicillin. Lung volumes stabilized (Table 2 ) , and arterial blood gases improved slightly. He continues to require low flow oxygen at home.
A 28-year-old lawyer was in good health until April 1971, when he developed transient arthralgias and stiffness of both knees and hemoptysis of 1 to 2 tablespoonsful daily. He was twice hospitalized locally where chest x-ray examination showed a left upper lobe infiltrate. Bronchoscopy and bronchograms gave negative results and multiple spuhlm cultures were negative for acid-fast bacilli, fungi, and pathogenic bacteria.
He was again hospitalized elsewhere when hemoptysis and migratory elbow, wrist, and shoulder pain increased. Open lung biopsy showed intra-alveolar organization, septal fibrosis, numerous interstitial and intra-alveolar iron-laden macrophages, and normal-appearing vasculah~re. Electron microscopy showed neither edema nor thickening of the basement membrane; no gamma globulin deposits were detected on the basement membrane. A muscle biopsy was normal. During that admission, the patient developed hematuria. The senun iron ( 22 mg percent) and total iron binding capacity ( 225 mg percent) were decreased; hematocrit was 27 percent. When he developed purpuric lesions on his elbows and legs, prednisone 40 mg daily was begun. His arthritis and skin lesions improved markedly, but hemoptysis of 30 to 100 ml daily persisted.
Dyspnea worsened, and he was transferred to the hlassachusetts General Hospital in August 1971. Admission examination revealed a young cyanotic man, tachypneic (60 respirations per minute), coughing copious amounts of bright red blood. Numerous excoriated purpuric lesions were present on Table M a s e 3 : Values the dorsunl of both feet and the lateral aspect of the left leg. Coarse rhonchi and fine rales were audible over the entire chest. There were small effusions of both knees.
Chest x-ray film demonstrated multiple bilateral nodular densities. At a flow rate of 7 liters of nasal oxygen per minute, Pa02 was 38; on 100 percent oxygen, administered by tight face mask, Pa02 rose only to 83. Tidal volume was 300 ml and vital capacity 900 ml. The patient was intr~bated and ventilated with a volume-cycled respirator. Positive end-expiratory pressure and methylprednisone ( 160 mg daily) were instituted, but hemoptysis persisted and Pa02 continued to deteriorate. Cy~lo~hosphamide, 900 mg as an intravenous bolus was administered on the third day. The drug was repeated 24 hours later.
Within 24 hours following the second dosage, hemoptysis decreased, and PaOz rose to 404 mnl Hg on 100 percent oxygen. Two days later, the patient could be extubated. By the tenth day, the patient was switched to oral prednisone (50 mg daily) and cyclophosphamide ( 150 mg daily).
Serial urinalyses showed 3+ proteinuria and up to 20 to 30 white and 6 to 8 red blood cells (with occasional hemoglobin casts) per high power field. Blood urea nitrogen and creatinine remained within normal limits. Immunoglobulin electrophoresis showed increased I&, IgA, and IgM. Serum complement was normal. Antinuclear antibody titer, Coombs' test, and three LE preparations were all negative. Sputum culture grew no pathogenic micro-organisms.
Pulmonary function tests \\.ere performed bvo weeks following admission (Table 3 ) . The patient was discharged on ~~clophosphamide 150 mg and prednisone 45 I I I~ daily. Steroids were tapered and discontinued two weeks later, and the immunosuppressive drug was stopped after five months. Serial studies showed return of total lung capacity to the normal range and progressive improvement in gas exchange. Only the diminished carbon monoxide diffusing capacity persists (Table 3) . Clinically, in May, 1974, the patient was working full time and was asymptomatic. Chest x-ray film reverted to nonnal.
Even with histologic diagnosis, the progress of interstitial pulmonary fibrosis cannot invariably be p r e d i~t e d .~.~ Consequently, in evaluation of drug therapy for a disease that can undergo spontaneous of 28-Year-Old M a n * exacerbation and remissions, it is difficult to separate drug effect from natural course of the disease. In our three patients, however, we were impressed that coincident with the use of immunosuppressive agents there was marked abatement (both clinical and physiologic) in previously rapidly progressing disease. The use of immunosuppressive therapy presupposes that interstitial pneumonitis can result from a derangement in the immunologic capacity of the host. As early as 1959, Read7 suggested that interstitial pulmonary fibrosis follows a consistent pattern of evolution from pulmonary allergy, and that immune mechanisms account for at least some stages of the process.
In interstitial pulmonary fibrosis, auto-antibody a b n~r m a l i t i e s ,~.~ elevations in at least one class of immunoglobulin^,^^ and deposition of circulating immunoglobulins in the alveolar septa11"2 have been documented. There also have been scattered reports of improvement in lung function with immunosuppressive therapy.l3.l4
Immunosuppressive therapy has also been successfully used in patients with other types of interstitial lung disease: cyclophosphamide and methotrexate in lethal midline granuloma,15.16 mercaptopurine in Goodpasture's syndrome,17 chlorambucil in Wegener's granulomatosis,ls and azathioprine in idiopathic pulmonary h e m o s i d e r o~i s .~~-~~ The course in our first two cases suggests that the major effect of immunosuppressive drugs is on the improvement of gas exchange rather than the reversal of restrictive defects. Since interstitial fibrosis includes both a cellular reactive phase and an irreversible fibrotic process, we suspect that the optimal time for immunosuppressive therapy would be in the proliferative or active phase of the disease. Impairment of gas exchange can be quite marked due to cellular deposition in the interstitium and subsequent ventilation/perfusion inequalities. Reversal of the inflammatory phase may prevent fibrotic changes and permanent loss of lung volume. On the other hand, in patients with primarily a scar-like picture on biopsy, it is unlikely that immunosuppressive agents would improve physiologic derangements.
Success with azathioprine and cyclophosphamide in this and other small series, coupled with evidence in the literature for at least a partial immunologic basis of interstitial lung disease, suggests that it may be desirable to initiate a multi-institution cooperative study to evaluate the efficacy of corticosteroids and immunosuppressive therapy in these disorders. Pending compilation of such statistical data, steroids remain the recommended treatment of interstitial lung disease, and consideration for immunosuppressive therapy should be reserved for patients with progressive deterioration on corticosteroid drugs.
